Literature DB >> 21893367

Hallucinogenic drugs in pre-Columbian Mesoamerican cultures.

F J Carod-Artal1.   

Abstract

INTRODUCTION: The American continent is very rich in psychoactive plants and fungi, and many pre-Columbian Mesoamerican cultures used them for magical, therapeutic and religious purposes.
OBJECTIVES: The archaeological, ethno-historical and ethnographic evidence of the use of hallucinogenic substances in Mesoamerica is reviewed.
RESULTS: Hallucinogenic cactus, plants and mushrooms were used to induce altered states of consciousness in healing rituals and religious ceremonies. The Maya drank balché (a mixture of honey and extracts of Lonchocarpus) in group ceremonies to achieve intoxication. Ritual enemas and other psychoactive substances were also used to induce states of trance. Olmec, Zapotec, Maya and Aztec used peyote, hallucinogenic mushrooms (teonanacatl: Psilocybe spp) and the seeds of ololiuhqui (Turbina corymbosa), that contain mescaline, psilocybin and lysergic acid amide, respectively. The skin of the toad Bufo spp contains bufotoxins with hallucinogenic properties, and was used since the Olmec period. Jimson weed (Datura stramonium), wild tobacco (Nicotiana rustica), water lily (Nymphaea ampla) and Salvia divinorum were used for their psychoactive effects. Mushroom stones dating from 3000 BC have been found in ritual contexts in Mesoamerica. Archaeological evidence of peyote use dates back to over 5000 years. Several chroniclers, mainly Fray Bernardino de Sahagún, described their effects in the sixteenth century.
CONCLUSIONS: The use of psychoactive substances was common in pre-Columbian Mesoamerican societies. Today, local shamans and healers still use them in ritual ceremonies in Mesoamerica.
Copyright © 2011 Sociedad Española de Neurología. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Alucinógenos; Culturas precolombinas; Hallucinogenic fungi; Hallucinogens; Hongos; Peyote; Pre-Columbian cultures; Psilocybe spp.; Turbina corymbosa

Mesh:

Substances:

Year:  2011        PMID: 21893367     DOI: 10.1016/j.nrl.2011.07.003

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  22 in total

1.  Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America.

Authors:  Melanie J Miller; Juan Albarracin-Jordan; Christine Moore; José M Capriles
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-06       Impact factor: 11.205

Review 2.  The promises and perils of psychedelic pharmacology for psychiatry.

Authors:  Tristan D McClure-Begley; Bryan L Roth
Journal:  Nat Rev Drug Discov       Date:  2022-03-17       Impact factor: 84.694

Review 3.  Psychedelics in the treatment of unipolar and bipolar depression.

Authors:  Oliver G Bosch; Simon Halm; Erich Seifritz
Journal:  Int J Bipolar Disord       Date:  2022-07-05

4.  Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.

Authors:  Joseph M Rootman; Maggie Kiraga; Pamela Kryskow; Kalin Harvey; Paul Stamets; Eesmyal Santos-Brault; Kim P C Kuypers; Zach Walsh
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

Review 5.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 6.  Biosynthesis and synthetic biology of psychoactive natural products.

Authors:  Cooper S Jamieson; Joshua Misa; Yi Tang; John M Billingsley
Journal:  Chem Soc Rev       Date:  2021-06-21       Impact factor: 60.615

Review 7.  Herbal Highs: Review on Psychoactive Effects and Neuropharmacology.

Authors:  Silvia Graziano; Laura Orsolini; Maria Concetta Rotolo; Roberta Tittarelli; Fabrizio Schifano; Simona Pichini
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

8.  Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.

Authors:  Roland R Griffiths; Ethan S Hurwitz; Alan K Davis; Matthew W Johnson; Robert Jesse
Journal:  PLoS One       Date:  2019-04-23       Impact factor: 3.240

Review 9.  The Therapeutic Potential of Psilocybin.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Henkel Valentine; Justin Grant; Amza Ali; Wilfred Ngwa; Lorenzo Gordon
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

Review 10.  The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.

Authors:  Manon Auffret; Sophie Drapier; Marc Vérin
Journal:  Drugs R D       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.